Darmstadt, Germany — Merck, a leading company for innovative and top- quality high-tech products in healthcare, life science and performance materials, today announced that Udit Batra, currently CEO and President of Merck Millipore, has been appointed to lead the combined life science business of Merck Millipore and Sigma- Aldrich once the acquisition of Sigma-Aldrich has […]

ST. LOUIS — Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that SAFC® Commercial (www.sigma-aldrich.com/safc), the Company’s business unit providing products and services for use in regulated pharmaceutical and biopharmaceutical applications, has launched the EX-CELL® Advanced™ product line. Designed to address the needs of an evolving industry where speed to market is paramount, the new product line […]

MADISON, WISCONSIN — Promega Corporation announces the launch of the new Nano-Glo® Dual-Luciferase® Reporter (NanoDLR™) Assay, a two-reporter system that incorporates NanoLuc® luciferase technology, providing increased data quality and greater sensitivity for biologically complex applications. The new NanoDLR assay allows researchers to measure NanoLuc and firefly luciferases together in a convenient, easy-to-use format. With improved […]

Los Altos, CA and Cambridge, MA — Genome Compiler Corp., a Los Altos based synthetic biology software company entered into a collaborative agreement with Addgene, a non-profit organization dedicated to sharing plasmids, located in Cambridge, MA. Genome Compiler will be integrating Addgene repository of plasmids into its advanced design tools and marketplace platform, enabling users […]

VENLO, The Netherlands -– QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced today that all current members of the Supervisory Board will stand for re-election for the standard one-year term at the next Annual General Meeting on June 23, 2015. In addition, Dr. Werner Brandt, the Chairman of the Supervisory Board, has decided to […]

South San Francisco, California — Nodality, Inc., which is focused on solving drug development challenges, announced today the availability of its new PathPro™ Chronic Lymphocytic Leukemia (CLL) panels. These panels are designed to characterize cell pathways associated with disease signaling at the single cell level and to analyze the activity of therapeutics commonly used or […]

BERKELEY, Calif. — Caribou Biosciences, a developer of CRISPR-Cas9 technologies for precision cell engineering, today announced that it has closed an $11 million Series A financing round. Investors include Fidelity Biosciences, Novartis, Mission Bay Capital, 5 Prime Ventures, and an undisclosed strategic partner. In addition, Dr. Jennifer Doudna, Investigator, Howard Hughes Medical Institute, Professor, U.C. […]

Salt Lake City, UT — Biosearch Technologies and Co-Diagnostics announced today an agreement allowing Biosearch to make, use, market and sell Co-Diagnostics’ CoPrimers™ technology to research institutions. The agreement also licenses CoPrimers™ technology to Biosearch for its own research and development. CoPrimers’™ unique patent-pending design greatly reduces the occurrence of primer-dimers, without the addition of […]

WOBURN, Mass. — Medicinal Genomics Corporation, a pioneer in the genomics of medicinal plants, today announced the availability of SenSATIVAx™, a highly robust and automated microbial DNA purification kit for Cannabis. “Medicinal Genomics’ SenSATIVAx™ Plant / Microbial DNA Purification Kit is quick and easy to use, requires minimal equipment, and produces a high quality purified […]